Bokf, Na Repligen Corp Transaction History

Bokf, Na

$5.65 Billion
Q3 2024

A detailed history of Bokf, Na transactions in Repligen Corp stock. As of the latest transaction made, Bokf, Na holds 2 shares of RGEN stock, worth $321. This represents 0.0% of its overall portfolio holdings.

Number of Shares

Previous 2 -0.0%

Holding current value

$321

Previous $0 NaN%

% of portfolio

0.0%

Previous 0.0%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$170.78 - $208.42 $170 - $208	1 Added 100.0%	2 $0
Q3 2023 Nov 14, 2023	SELL	$138.78 - $176.51 $23,315 - $29,653	-168 Reduced 99.41%	1 $0
Q2 2023 Aug 21, 2023	SELL	$138.42 - $180.31 $11,350 - $14,785	-82 Reduced 32.67%	169 $23,000
Q1 2023 May 11, 2023	BUY	$154.26 - $198.1 $38,719 - $49,723	251 New	251 $42,000
Q2 2022 Aug 11, 2022	SELL	$140.68 - $188.02 $166,846 - $222,991	-1,186 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$161.19 - $257.96 $18,698 - $29,923	-116 Reduced 8.91%	1,186 $223,000
Q4 2021 Mar 11, 2022	SELL	$247.59 - $304.47 $3,466 - $4,262	-14 Reduced 1.06%	1,302 $345,000
Q3 2021 Nov 10, 2021	BUY	$194.77 - $324.21 $256,317 - $426,660	1,316 New	1,316 $380,000
Q1 2021 Apr 21, 2021	SELL	$180.37 - $226.26 $216,985 - $272,190	-1,203 Closed	0 $0
Q4 2020 Feb 12, 2021	SELL	$148.08 - $206.57 $36,575 - $51,022	-247 Reduced 17.03%	1,203 $231,000
Q3 2020 Oct 30, 2020	BUY	$122.51 - $158.27 $177,639 - $229,491	1,450 New	1,450 $214,000

Others Institutions Holding RGEN

# of Institutions

489

Shares Held

54.2M

Call Options Held

341K

Put Options Held

235K

Black Rock Inc. New York, NY

7.57M
Shares

$1.21 Billion
0.02% of portfolio
Price T Rowe Associates Inc Baltimore, MD

6.39M
Shares

$1.03 Billion
0.11% of portfolio
Vanguard Group Inc Valley Forge, PA

5.04M
Shares

$810 Million
0.01% of portfolio
State Street Corp Boston, MA

1.62M
Shares

$261 Million
0.01% of portfolio
Champlain Investment Partners, LLC Burlington, VT

1.42M
Shares

$228 Million
1.34% of portfolio

View Full List

About REPLIGEN CORP

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $8.91B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

More about RGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bokf, Na, based on Form 13F filings with the SEC.

News

Stay updated on Bokf, Na with notifications on news.

Account